scholarly article | Q13442814 |
review article | Q7318358 |
meta-analysis | Q815382 |
P356 | DOI | 10.1136/BMJ.38302.504063.8F |
P8608 | Fatcat ID | release_tjzqou7curbmfpedk6gaf3jdhi |
P932 | PMC publication ID | 543862 |
P698 | PubMed publication ID | 15596418 |
P2093 | author name string | Bahi Takkouche | |
Ali Samii | |||
Mahyar Etminan | |||
Francisco Caamaño Isorna | |||
P2860 | cites work | Bias in meta-analysis detected by a simple, graphical test | Q24685585 |
A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease | Q34526685 | ||
Migraine and risk of ischaemic stroke: a case-control study | Q35189202 | ||
Duration, frequency, recency, and type of migraine and the risk of ischaemic stroke in women of childbearing age. | Q35560151 | ||
Case-control study of migraine and risk of ischaemic stroke in young women | Q36902964 | ||
Migraine and stroke in young women: case-control study. The World Health Organisation Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception | Q37398612 | ||
Prospective study of endogenous tissue plasminogen activator and risk of stroke | Q41036094 | ||
Contraceptives and cerebral thrombosis: a five-year national case-control study | Q43945036 | ||
Ischemic stroke in young women: a nested case-control study using the UK General Practice Research Database. | Q44895974 | ||
Focal cerebral ischemia in young adults: a collaborative case-control study. The National Research Council Study Group | Q45288611 | ||
Stroke and use of low-dose oral contraceptives in young women: a pooled analysis of two US studies | Q46306495 | ||
Focal ischaemia caused by instability of cerebrovascular tone during attacks of hemiplegic migraine. A regional cerebral blood flow study | Q48223320 | ||
The association between migraine and juvenile stroke: a case-control study | Q48398823 | ||
Lifestyle-associated risk factors for acute brain infarction among persons of working age. | Q48821745 | ||
Association between migraine and stroke in a large-scale epidemiological study of the United States. | Q50961206 | ||
History of migraine and risk of cerebral ischaemia in young adults. The Italian National Research Council Study Group on Stroke in the Young. | Q51026135 | ||
HEpiMA: software for the identification of heterogeneity in meta-analysis. | Q52069541 | ||
Cognitive and behavioral outcomes of school-aged children who were born preterm: a meta-analysis. | Q52116271 | ||
Oral contraceptives and stroke in young women. Associated risk factors | Q67311784 | ||
A controlled study of ischemic stroke risk in migraine patients | Q69681175 | ||
A population-based study of stroke in the setting of mitral valve prolapse: risk factors and infarct subtype classification | Q72024278 | ||
Oral contraceptives, pregnancy and the risk of cerebral thromboembolism: the influence of diabetes, hypertension, migraine and previous thrombotic disease | Q72251406 | ||
Migraine and subsequent risk of stroke in the Physicians' Health Study | Q72526338 | ||
Brief report: bilateral spreading cerebral hypoperfusion during spontaneous migraine headache | Q72827986 | ||
Role of anticardiolipin antibodies in young persons with migraine and transient focal neurologic events: a prospective study | Q74575122 | ||
Migraine as a risk factor for subclinical brain lesions | Q75347052 | ||
Evaluation of old and new tests of heterogeneity in epidemiologic meta-analysis | Q78020104 | ||
Migraine | Q79890177 | ||
P433 | issue | 7482 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | migraine | Q133823 |
systematic review | Q1504425 | ||
meta-analysis | Q815382 | ||
P304 | page(s) | 63 | |
P577 | publication date | 2004-12-13 | |
P1433 | published in | The BMJ | Q546003 |
P1476 | title | Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies | |
P478 | volume | 330 |
Q34613373 | "Migraine side effect" and stroke recurrence in late follow-up after transcatheter patent foramen ovale closure as secondary prevention of cryptogenic thromboembolism |
Q48096636 | A Diagnostic Approach to Stroke in Young Adults |
Q37102490 | ACE D/I polymorphism, migraine, and cardiovascular disease in women |
Q48425234 | Acute migraine-associated borderzone cerebellar infarction |
Q36819812 | Advanced neuroimaging of migraine |
Q37802044 | Aetiological diagnosis of ischaemic stroke in young adults |
Q36243293 | Age-specific association of migraine with cryptogenic TIA and stroke: Population-based study |
Q47825982 | An investigation in the possible effect of chronic headache on neuropsychological function in aCL-negative patients with SLE. |
Q36277248 | Antithrombotic therapy for stroke in young adults |
Q80166989 | Are migraine and headache associated with an increased risk of stroke in women? |
Q91640930 | Assessing hormonal contraceptive dispensing and counseling provided by community pharmacists in the United Arab Emirates: a simulated patient study |
Q36755722 | Assessment of pyridoxine and folate intake in migraine patients |
Q36259587 | Association between Chlamydia pneumoniae IgG antibodies and migraine |
Q35045738 | Association between ischemic stroke and migraine in elderly Chinese: a case-control study |
Q36941889 | Associations between migraine and cardiovascular disease |
Q52661731 | Basilar Artery Lateral Displacement May Be Associated with Migraine with Aura. |
Q33773471 | Biphasic direct current shift, haemoglobin desaturation and neurovascular uncoupling in cortical spreading depression |
Q48363932 | Brain MRI white matter lesions in migraine patients: is there a relationship with antiphospholipid antibodies and coagulation parameters? |
Q36054050 | CADASIL: Migraine, Encephalopathy, Stroke and Their Inter-Relationships. |
Q37630537 | CSD, BBB and MMP-9 elevations: animal experiments versus clinical phenomena in migraine |
Q47152467 | Case Report: Migrainous Infarct without Aura |
Q59740118 | Chapter 17 Stroke among women, ethnic groups, young adults, and children |
Q35945173 | Clinical evaluation of patients with migraine induced stroke in mashhad, iran. |
Q47767543 | Clinical outcomes of secondary prevention strategies for young patients with cryptogenic stroke and patent foramen ovale |
Q60046391 | Clinical relevance of atrial septal aneurysm and patent foramen ovale with migraine |
Q38747848 | Coincidental Impact of Transcatheter Patent Foramen Ovale Closure on Migraine with and without Aura - A Comprehensive Meta-Analysis |
Q55429933 | Combined hormonal contraception use in reproductive-age women with contraindications to estrogen use. |
Q37973415 | Combined hormonal contraceptives: is it time to reassess their role in migraine? |
Q36260205 | Comorbid neuropathologies in migraine: an update on cerebrovascular and cardiovascular aspects. |
Q38013723 | Comorbidity in perimenstrual migraine |
Q37178326 | Confidence intervals for heterogeneity measures in meta-analysis |
Q38083769 | Contraception and headache |
Q37186251 | Contraception in women with medical problems |
Q90426341 | Coronary artery calcification score in migraine patients |
Q39157399 | Correlation between Migraine Severity and Cholesterol Levels. |
Q37263423 | Current views of the risk of stroke for migraine with and migraine without aura |
Q47562217 | Determinants of glucose metabolism and the role of NPY in the progression of insulin resistance in chronic migraine |
Q93156909 | Differences in treatment response between migraine with aura and migraine without aura: lessons from clinical practice and RCTs |
Q45819076 | Diffusion-weighted lesions in acute ischaemic stroke patients with migraine. |
Q38344344 | Dissecting the association between migraine and stroke |
Q35666284 | Effects of pyridoxine supplementation on severity, frequency and duration of migraine attacks in migraine patients with aura: A double-blind randomized clinical trial study in Iran |
Q52607697 | Elevated S100B and neuron specific enolase levels in patients with migraine-without aura: evidence for neurodegeneration? |
Q26752352 | Embolic Strokes of Unknown Source and Cryptogenic Stroke: Implications in Clinical Practice |
Q34714052 | Enalapril improves endothelial function in patients with migraine: A randomized, double-blind, placebo-controlled trial |
Q35184010 | Endothelial Function in Patients with Migraine without Aura during the Interictal Period |
Q35535243 | Endothelial function in migraine with aura - a systematic review. |
Q24241065 | Escitalopram versus other antidepressive agents for depression |
Q89110504 | Estrogen, migraine, and vascular risk |
Q37809855 | Estrogen-Free Oral Hormonal Contraception: Benefits of the Progestin-Only Pill |
Q37422375 | Ethical diversity and the role of conscience in clinical medicine |
Q51668026 | Evaluation of carotid intima-media thickness in children with migraine: a marker of subclinical atherosclerosis. |
Q40772391 | Evaluation of migraine in patients with ischaemic stroke. |
Q84212867 | Fabry disease in patients with migraine with aura |
Q38014163 | Frequency and etiological diagnosis of ischemic stroke in Chinese young adults |
Q88322102 | Frequency of Patent Foramen Ovale and Migraine in Patients With Cryptogenic Stroke |
Q46917269 | Frequency of migraine and the risk of cardiovascular disease for women: limited evidence of an association |
Q46011691 | Genomic profiles for human peripheral blood T cells, B cells, natural killer cells, monocytes, and polymorphonuclear cells: comparisons to ischemic stroke, migraine, and Tourette syndrome. |
Q37251490 | Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association |
Q38609011 | Headache Rounds: Sudden, Transient Neurologic Symptoms in a Woman With Migraine |
Q37798812 | Headache and cardiovascular disease: old symptoms, new proposals. |
Q44984989 | Headache as a risk factor for dementia: a prospective population-based study |
Q36889587 | Heart-brain signaling in patent foramen ovale-related stroke: differential plasma proteomic expression patterns revealed with a 2-pass liquid chromatography-tandem mass spectrometry discovery workflow |
Q90568763 | History of Migraine and Volume of Brain Infarcts: The Italian Project on Stroke at Young Age (IPSYS) |
Q37075316 | Hormonal contraception in women with migraine: is progestogen-only contraception a better choice? |
Q35144750 | Hormonal contraception--what kind, when, and for whom? |
Q37788968 | Hormonal contraceptive options for women with headache: a review of the evidence |
Q47142161 | Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC). |
Q37591553 | Hormonal therapies for menstrual migraine |
Q47235360 | Increased receptor activity-modifying protein 1 in the nervous system is sufficient to protect against autonomic dysregulation and hypertension. |
Q48394507 | Interictal cerebral and systemic endothelial dysfunction in patients with migraine: a case-control study. |
Q36925334 | Interrelationships among the MTHFR 677C>T polymorphism, migraine, and cardiovascular disease |
Q35707665 | Iron accumulation in deep brain nuclei in migraine: a population-based magnetic resonance imaging study |
Q44060373 | Is migraine with aura associated with increased risk of cardiovascular disease? |
Q64892470 | Ischemic stroke in the young: Current perspectives on incidence, risk factors, and cardiovascular prognosis. |
Q26824314 | Ischemic stroke in young adults: an overview of etiological aspects |
Q40428209 | Ischemic stroke subtypes and migraine with visual aura in the ARIC study |
Q92977138 | Lasmiditan for acute treatment of migraine in patients with cardiovascular risk factors: post-hoc analysis of pooled results from 2 randomized, double-blind, placebo-controlled, phase 3 trials |
Q43227931 | Lipid profile in normal weight migraineurs - evidence for cardiovascular risk |
Q33394850 | Lipoprotein (a) [Lp(a)]: a possible link between migraine and stroke |
Q36649954 | Long-term follow-up after percutaneous closure of patent foramen ovale with Amplatzer PFO Occluder: a single center experience |
Q33925703 | MTHFR 677C->T and ACE D/I polymorphisms and migraine attack frequency in women |
Q36941893 | Menstrual migraine: clinical and therapeutical aspects |
Q82295119 | Meta-analysis of results from case control and cohort studies finds that migraine is associated with approximately twice the risk of ischaemic stroke |
Q51498300 | Metabolic and genetic risk factors for migraine in children. |
Q34066973 | Microemboli may link spreading depression, migraine aura, and patent foramen ovale |
Q57811769 | Migraine |
Q38767493 | Migraine Headache and Long-Term Cardiovascular Outcomes: An Extended Follow-Up of the Women's Ischemia Syndrome Evaluation. |
Q90570529 | Migraine Headache and Risk of Dementia in the Atherosclerosis Risk in Communities Neurocognitive Study |
Q56976968 | Migraine and Stroke |
Q37693868 | Migraine and Stroke: What's the Link? What to Do? |
Q46912160 | Migraine and biomarkers of cardiovascular disease in women. |
Q37608416 | Migraine and cardiocerebrovascular risk in women. |
Q36292268 | Migraine and cardiovascular disease: a population-based study |
Q37213760 | Migraine and cardiovascular disease: possible mechanisms of interaction |
Q24647568 | Migraine and cardiovascular disease: systematic review and meta-analysis |
Q48369207 | Migraine and cerebral infarction in young people |
Q89110510 | Migraine and cerebrovascular disease: still a dangerous connection? |
Q37750594 | Migraine and cerebrovascular risk. |
Q46946198 | Migraine and delayed ischaemic neurological deficit after subarachnoid haemorrhage in women: a case-control study |
Q40914789 | Migraine and endothelial function: The HUNT3 Study |
Q38371291 | Migraine and epilepsy: review of the literature |
Q30813640 | Migraine and estrogen |
Q37581975 | Migraine and genetic and acquired vasculopathies |
Q42714575 | Migraine and ischaemic stroke |
Q36895947 | Migraine and ischaemic vascular events. |
Q37156443 | Migraine and ischemic stroke: a debated question |
Q34081981 | Migraine and risk of haemorrhagic stroke in women: prospective cohort study |
Q90690383 | Migraine and risk of stroke |
Q41633495 | Migraine and risk of stroke and acute coronary syndrome in two case-control studies in the Danish population |
Q47664254 | Migraine and risk of stroke: a national population-based twin study |
Q33240072 | Migraine and stroke--why do we talk about it? |
Q34305267 | Migraine and stroke: "vascular" comorbidity |
Q34240928 | Migraine and stroke: a complex association with clinical implications |
Q38099675 | Migraine and stroke: a continuum of association in adults |
Q37282908 | Migraine and stroke: current perspectives |
Q38250305 | Migraine and stroke: in search of shared mechanisms |
Q37188595 | Migraine and stroke: the role of oral contraceptives |
Q30838502 | Migraine and the risk for stroke and cardiovascular disease. |
Q37356477 | Migraine and the risk of coronary heart disease and ischemic stroke in women |
Q38019918 | Migraine and vascular diseases: a review of the evidence and potential implications for management |
Q37591540 | Migraine as a potential risk factor for ischemic lesions: recent findings |
Q40792795 | Migraine as a predictor of mortality: The HUNT study |
Q40382529 | Migraine as a risk factor for young patients with ischemic stroke: a case-control study |
Q34066772 | Migraine aura pathophysiology: the role of blood vessels and microembolisation |
Q56977071 | Migraine frequency and risk of cardiovascular disease in women |
Q33976705 | Migraine headache and ischemic stroke risk: an updated meta-analysis |
Q37558323 | Migraine in the triptan era: progresses achieved, lessons learned and future developments |
Q46065193 | Migraine is a risk factor for sudden sensorineural hearing loss: a nationwide population-based study |
Q33157483 | Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: the population-based MRI CAMERA study |
Q35746941 | Migraine mutations increase stroke vulnerability by facilitating ischemic depolarizations |
Q33695265 | Migraine prevalence in patients with unruptured intracranial aneurysms: A case-control study |
Q37244756 | Migraine with and without aura and risk for cardiovascular disease |
Q38504718 | Migraine with aura and patent foramen ovale: myth or reality? |
Q50006074 | Migraine with aura and persistent foramen ovale |
Q34907687 | Migraine with aura is associated with an incomplete circle of willis: results of a prospective observational study |
Q43796279 | Migraine with aura: a predictor of patent foramen ovale in children and adolescents |
Q38504714 | Migraine with aura: which patients are most at risk of stroke? |
Q38259062 | Migraine, cardiovascular disease, and stroke during pregnancy: systematic review of the literature |
Q36239499 | Migraine, cerebrovascular disease and the metabolic syndrome |
Q47830067 | Migraine, menopause and hormone replacement therapy. |
Q33936800 | Migraine, migraine features, and cardiovascular disease |
Q36825792 | Migraine, vascular risk, and cardiovascular events in women: prospective cohort study |
Q34657504 | Migraine-associated risks and comorbidity |
Q37136848 | Migraines during pregnancy linked to stroke and vascular diseases: US population based case-control study |
Q36259637 | Migraineurs with patent foramen ovale have larger right-to-left shunt despite similar atrial septal characteristics |
Q46194418 | Migrainous infarction: a Nordic multicenter study |
Q39456116 | Migrainous infarction: a rare and often overlooked diagnosis |
Q38004939 | Migrainous infarction: aspects on risk factors and therapy. |
Q46025561 | Migrainous infarction: association with vascular risk factors in a male subject. |
Q31120792 | Misdiagnosis of stroke |
Q36750079 | New insights into the cardiovascular risk of migraine and the role of white matter hyperintensities: is gold all that glitters? |
Q37490270 | Newest aspects on the association between migraine and cardiovascular disease: the role of modifying factors |
Q33234926 | No role for estrogen receptor 1 gene intron 1 Pvu II and exon 4 C325G polymorphisms in migraine susceptibility. |
Q37409501 | Oral contraceptives in migraine |
Q36450684 | Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis--part 2. |
Q58797905 | PACAP38 and PAC receptor blockade: a new target for headache? |
Q37926316 | Paradoxical embolism, stroke and sclerotherapy |
Q37556480 | Patent Foramen Ovale With Atrial Septal Aneurysm Is Strongly Associated With Migraine With Aura: A Large Observational Study. |
Q36549645 | Patent foramen ovale and cerebrovascular diseases |
Q44005291 | Patterns of prescription and usage of triptans in Alsace (France): misuse is frequent and avoidable |
Q36986385 | Peculiarities of stroke risk in women. |
Q40031656 | Peripheral endothelial function and arterial stiffness in women with migraine with aura: a case-control study |
Q35533552 | Physical comorbidity of migraine and other headaches in US adolescents |
Q30536711 | Polymorphisms in migraine-associated gene, atp1a2, and ischemic stroke risk in a biracial population: the genetics of early onset stroke study. |
Q39414283 | Posttraumatic migraine as a predictor of recovery and cognitive impairment after sport-related concussion. |
Q34551627 | Practical considerations for the treatment of elderly patients with migraine |
Q62692646 | Prevalence and characteristics of right-to-left shunt in migraine with aura: a survey on 120 Italian patients |
Q37276491 | Prevention of cardiovascular diseases: Role of exercise, dietary interventions, obesity and smoking cessation. |
Q52368754 | Protective effects of PACAP in ischemia. |
Q51025787 | Prothrombotic states in migraine. |
Q37168913 | Pulmonary arteriovenous malformations and migraine: a new vision |
Q51433580 | Pulse wave velocity study in middle-aged migraineurs at low cardiovascular disease risk. |
Q34371293 | Quality of systematic reviews of observational nontherapeutic studies |
Q38892560 | Rare Complications of Migraine With Aura |
Q36234341 | Relation between migraine and stroke |
Q37657614 | Review of comorbidities and risk factors for the development of migraine complications (infarct and chronic migraine). |
Q34472618 | Risk factors for ischemic stroke and transient ischemic attack in patients under age 50 |
Q47594531 | Risk of Stroke Associated With Use of Estrogen Containing Contraceptives in Women With Migraine: A Systematic Review |
Q36869870 | Risk of Stroke in Migraineurs Using Triptans. Associations with Age, Sex, Stroke Severity and Subtype |
Q34214948 | Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case-control studies. |
Q37071328 | Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies |
Q37149840 | Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes |
Q30241432 | Sex differences in the epidemiology, clinical features, and pathophysiology of migraine |
Q34747142 | Shall Migraine be Considered a Simple Benign Headache Disorder? |
Q30366137 | Shared genetic basis for migraine and ischemic stroke: A genome-wide analysis of common variants. |
Q92833737 | Solving the conundrum. A migrainous infarction or an infarct-induced migrainous attack? |
Q38218958 | Spreading depolarization may link migraine and stroke |
Q37868357 | Stroke in young women. |
Q45155502 | Stroke, migraine, and headache |
Q42529297 | Strong association between right-to-left shunt and migraine |
Q47156884 | The Levels of Circulating Proangiogenic Factors in Migraineurs. |
Q26747260 | The Migraine-Stroke Connection |
Q34112584 | The association of migraine with ischemic stroke |
Q37208182 | The association of migraine with menstrually related mood disorders and childhood sexual abuse |
Q37086851 | The brain's heart - therapeutic opportunities for patent foramen ovale (PFO) and neurovascular disease |
Q38157892 | The changing landscape of voltage-gated calcium channels in neurovascular disorders and in neurodegenerative diseases |
Q41774597 | The clinical profile and prognosis of Chinese children with melamine-induced kidney disease: a systematic review and meta-analysis |
Q43710524 | The evaluation of atherosclerosis in migraine patients. |
Q34963196 | The migraine association with cardiac anomalies, cardiovascular disease, and stroke |
Q38373700 | The qualitative problem of major quotation errors, as illustrated by 10 different examples in the headache literature |
Q37568704 | The relationship between right-to-left shunt and brain white matter lesions in Japanese patients with migraine: a single center study |
Q37989174 | The role of the MTHFR gene in migraine |
Q36364915 | The role of vascular and hormonal genes in migraine susceptibility. |
Q48907575 | The use of progestogen-only pill in migraine patients |
Q36654399 | Transcatheter closure of patent foramen ovale in patients with migraine headache |
Q41641941 | Trigeminal neuralgia increases cerebral blood flow in a focal cerebral ischemic model in rats. |
Q34595006 | Two young patients with stroke in conjunction with migraineus headache |
Q34482554 | Update in women's health for the general internist. |
Q28535971 | Use of simulated patients to evaluate combined oral contraceptive dispensing practices of community pharmacists |
Q48939295 | What happens to new-onset headache presented to primary care? A case-cohort study using electronic primary care records |
Q79783548 | [Patent foramen ovale and migraine] |
Search more.